Immunosuppressive agents

LE WE PMID CA

Immunosuppressive agents

1304

Immunsuppressiva

Adenosine

Alefacept

Arginase

Belatacept ttCD80 ttCD86

Belimumab ttBLyS

Calcineurin

CD39

CD73

Ecstasy

Eculizumab ttFactorH

Efalizumab ttLFA1

Epratuzumab ttCD22

Ghrelin

Immune deviation

Immunosuppressive agents

Immunotherapy (Adoptive cell transfer)

Infliximab ttTNFalpha

Liver (Transplantation)

MSH

Neutrophils

NFAT

QPI1002 ttp53

Receptor (PPAR)

Regulatory T cell

Repertaxin ttCXCR1 ttCXCR2

Rituximab ttCD20

RPSGLIG ttPSelectin

Tocilizumab ttIL6

TP10 ttsCR3

Ultraviolet radiation (Toxicology)

1996 1	Immunosuppression in organ transplantation. [8835634] Jpn J Pharmacol 71(2): 89-100 (1996)
1994 2	Therapeutic advances in immunosuppression. [7994898] Clin Exp Immunol 98(3): 351-7 (1994)
1999 3	Newer immunosuppressive drugs: a review. [10361877] J Am Soc Nephrol 10(6): 1366-80 (1999)
2008 4	Pharmacokinetic principles of immunosuppressive drugs. [18806727] Ann Transplant 13(3): 5-10 (2008)
2008 5	Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. [19065796] Adv Exp Med Biol 640(-): 234-51 (2008)
2009 6	The pharmacology of immunosuppression. [20221337] Am J Pharm Educ 73(8): 144 (2009)
2007 7	PPARs and molecular mechanisms of transrepression. [17433773] Biochim Biophys Acta 1771(8): 926-35 (2007)
2005 8	Immunosuppression in liver transplantation: beyond calcineurin inhibitors. [15719409] Liver Transpl 11(3): 267-80 (2005)
2008 9	Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. [18612139] Endocr Rev 29(5): 581-602 (2008)
2009 10	Ghrelin: friend or foe for neuroinflammation. [19788870] Discov Med 8(41): 64-7 (2009)
2010 11	Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? [20718737] Br J Pharmacol 161(1): 17-32 (2010)
2008 12	Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. [18311159] Br J Pharmacol 153 Suppl 1(-): S457-64 (2008)
2009 13	Arginase: an emerging key player in the mammalian immune system. [19764983] Br J Pharmacol 158(3): 638-51 (2009)
2010 14	Antibody immunosuppressive therapy in solid organ transplant: Part II. [20948291] MAbs 2(6): 607-12 (2010)
2010 15	Antibody immunosuppressive therapy in solid-organ transplant: Part I. [20150766] MAbs 2(2): 148-56 (2010)
2010 16	The dark and the sunny sides of UVR-induced immunosuppression: photoimmunology revisited. [19626036] J Invest Dermatol 130(1): 49-54 (2010)
2010 17	Surgical biology for the clinician: vascular effects of immunosuppression. [20100415] Can J Surg 53(1): 57-63 (2010)
2003 18	Reprogramming immune responses: enabling cellular therapies and regenerative medicine. [12529548] Stem Cells 21(1): 21-32 (2003)
2009 19	Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? [19860902] Cell Commun Signal 7(-): 25 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunosuppressive agents.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunosuppressive agents.php on line 92